Moderna Begins Testing its COVID-19 Vaccine in Young Children
U.S.-based pharmaceutical company Moderna has begun testing its two-dose COVID-19 vaccine in young children to determine if vaccinations should be expanded to people younger than 18 years of age. The company will administer the vaccine to about 6,750 children in the United States and Canada between the ages…